Navigation Links
3SBio Inc. Announces Unaudited Third Quarter 2009 Results
Date:11/12/2009

7,748 12,130 1,777 Prepaid expenses and other receivables 8,249 9,260 1,357 Deferred tax assets 1,802 2,581 378 Total current assets 824,612 857,246 125,583 Available-for-sale securities 26,700 14,682 2,151 Property, plant and equipment, net 78,185 139,263 20,401 Lease prepayments 8,894 8,629 1,264 Non-current deposits 8,521 15,596 2,285 Intangible assets, net 5,225 4,400 645 Deferred tax assets 781 106 16 Total assets 952,918 1,039,922 152,345 Liabilities Current liabilities Accounts payable 1,939 3,062 449 Deferred grant income 374 374 55 Accrued expenses and other payables 25,273 35,569 5,211 Income tax payable 1,256 3,323 487 Other current liabilities 57 -- -- Total current liabilities 28,899 42,328 6,202 Deferred grant income 3,152 2,871 421 Other liabilities 472 -- -- Total liabilities 32,523 45,199 6,623 Commitments and contingencies -- -- -- Shareholders' equity Share capital - ordinary shares US$0.0001 par value, 500,000,000 shares authorized, 150,575,955 and 150,635,189 issued and outstanding as of December 31, 2008 and September 30, 2009, respectively 121 121 18 Additional paid-in capital 908,3
'/>"/>
SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
2. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
3. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
4. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
5. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
6. 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
7. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
8. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
9. 3SBio Inc. Announces Third Quarter 2008 Results
10. 3SBio Inc. Files for SFDA Approval of NuLeusin
11. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 US-Australian drug ... ) today confirmed it is committed to progressing its ... soon as practicable and to ensure the Company delivers ... Executive Officer, Iain Ross , said the Company ... the lead pre-clinical programs, discovery programs and academic partnerships ...
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., the leading ... 2nd generation cell therapy POD® design. The 2nd generation portfolio not only delivers ... new POD® design. , “G-CON first offered our miniPOD CT product line ...
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  Pfenex ... quarter 2015 financial results will be released on Thursday, ... 8:30 am Eastern Time, Pfenex management will host a ... a business update.  A press release outlining the financial ... to the call. Please call 1-866-376-8058 (US) ...
(Date:7/29/2015)... ... 29, 2015 , ... Finding gooey or crusty material in the corner of ... a considerable number of terms in popular use to describe it, ophthalmologists call it ... of mucus, blood cells, skin cells and dust, but until now there has been ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 4
... plc (LSE: SHP, NASDAQ:, SHPGY ), the global specialty biopharmaceutical company, announces that at its,Annual General Meeting today, ... , , ... For* Against Withheld**, 1. ... together with the, ...
... BeaconEquity.com announces the availability of Stock Alerts on stocks making ... stocks are parading up the charts. So how does swine ... three stocks (BCRX, AVII, DVAX) reeling from influenza news that ... stockhideout.com .Today,s Stock Alerts include: ...
... US Oncology, Inc. will announce its financial results for the ... conference call and simultaneous webcast will be hosted by management ... Additional information will be available on the company,s Web site, ... the day of the earnings announcement. US/Canada Dial-in #: ...
Cached Biology Technology:Shire plc: Results of the Annual General Meeting Held on April 28, 2009 2Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA 2Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA 3US Oncology to Report 2009 First Quarter Operating Results 2
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... Light of specific wavelengths can be used to boost an enzyme,s ... to less expensive biofuels, detergents and a host of other products. ... Chemistry Letters, a team led by Pratul Agarwal of the ... aims to improve upon nature and it happens in the ...
... (April. 17, 2012) Combined, complimentary therapies have the ... (NSC) transplantation for spinal cord repair in rat models, ... of Korean researchers who published in a recent issue ... http://www.ingentaconnect.com/content/cog/ct/ ., "When transplanted, neural stem cells ...
... MINNETONKA, Minn., April 17, 2012 MedNet Solutions, a ... management systems, is pleased to announce its participation in ... held April 24-26 at the World Trade Center in ... company,s entire lineup of innovative, flexible and reliable cloud-based ...
Cached Biology News:ORNL process improves catalytic rate of enzymes by 3,000 percent 2Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies 2MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo 2
... PHD2000 syringe pump series combines Harvard Apparatuss best ... and a wide range of configuration options. A ... dimensions of syringes from all the major manufacturers. ... all the pertinent information from across the lab. ...
Mouse monoclonal antibody to RAD51L3 - RAD51-like 3 (S. cerevisiae)...
... you to store and manage very large ... secure central relational database. Storing and managing ... resource for clone tracking and enables you ... analysis. LabShare software integrates seamlessly with Invitrogen's ...
... A and Protein G bind specifically to ... A and Protein G conjugates are commonly ... (antibodies) and immunoglobulin subtypes from serum, hybridoma ... biological fluids. These reagents are also commonly ...
Biology Products: